Neurologists Describe Childhood Absence Epilepsy as 'Underrecognized' but 'Easily Diagnosed and Treated'
Expanding awareness of Childhood Absence Epilepsy helps early diagnosis and treatment
WASHINGTON, May 6, 2024 /PRNewswire/ -- The subtlety of childhood absence epilepsy (CAE) seizures, coupled with their close association with learning and mental health difficulties, can delay diagnosis despite CAE being one of the most common pediatric syndromes in the United States, according to a new expert-led clinical proceedings paper from the Clinical Neurological Society of America.
Childhood absence epilepsy seizures are brief staring spells with loss of awareness that cannot be interrupted by voice or touch. Seizures can occur multiple times per day. CAE may go undiagnosed or misdiagnosed because it can be mistaken for ADHD or be difficult for parents, teachers and other caregivers to recognize. While CAE usually remits within two years of onset or by early adolescence, the impact on children's social and emotional health can be long term.
Improving awareness of the disease among parents, teachers, health care providers and the community at large;
Increasing understanding of its link to ADHD and other learning and mental health challenges; and
Improving access to diagnosis and treatment.
Expert Panelists:
Katy Lalor, MD (Clinical Proceedings Chair)
Allison Conravey, MD
Sudha Kilaru Kessler, MD
Elaine C. Wirrell, MD
Statement from Katy Lalor, MD, Clinical Proceedings Chair:
"Expanding awareness among the public of CAE is the first step to earlier diagnosis and treatment. And with a greater understanding of CAE's link to ADHD and other learning and mental health challenges, we can reduce the burden of this disease and improve the short-term and long-term outcomes of these children."
The Clinical Neurological Society of America, a non-profit 501(c)(6), is a nationwide organization of neurology clinicians with a mission to improve clinical practice and patient care through education.
The report "Anti-Migrating Agent Market by Type (Non-ionic, Anionic, Cationic, Amphoteric), Grades (Technical, Food, Pharmaceutical), Application, Chemistry (Organic, Inorganic), End-Use Industry (Textile, Plastics, Paper), and Region - Global...
Gupshup, the world's leading Conversation Cloud, in collaboration with Meta, the Sudan Medical Specialization Board and non-profit Shabaka today announced the launch of a telemedicine chatbot providing healthcare access for Sudanese refugees in...
The revenue in June for Zinzino's sales markets increased by 13% and amounted to SEK 148.5 (131.4) million. Faun Pharma's external sales decreased and amounted to SEK 5.8 (8.5) million. Overall, the Group increased revenues by 10% to SEK 154.3...
The global Specialty Enzymes Market size is estimated to be valued at USD 6.1 billion in 2024 and is projected to reach USD 9.2 billion by 2029, recording a CAGR of 8.5% from 2024 to 2029 according to a report published by MarketsandMarketstm. The...
Kvantify, a leading quantum software start-up, has announced the successful closure of a EUR 10 million seed round. This funding will enable Kvantify to strengthen its position as a global leader in quantum computing, with an initial focus on...
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Cytotoxic Drugs and HPAPI Manufacturing Market- (Type of Product (HPAPI and highly potent finished dosage form), Company Size (Small, Mid-sized, Large,...